DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 15 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 500,000 | $1,420,000 | 3.26% |
| Altium Capital Management LP | 287,698 | $817,062 | 0.56% |
| Bleichroeder LP | 222,317 | $631,380 | 0.14% |
| COOPERMAN LEON G | 1,767,246 | $5,018,978 | 0.12% |
| Aristides Capital LLC | 106,333 | $301,986 | 0.11% |
| CATALYST FINANCIAL PARTNERS LLC | 36,267 | $102,998 | 0.03% |
| Naples Money Management LLC | 3,878 | $11,014 | 0.01% |
| Stonebridge Capital Advisors LLC | 20,000 | $56,800 | 0.01% |
| Legend Financial Advisors, Inc. | 1,000 | $2,840 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 114,744 | $325,872 | 0.00% |